Jonathan Schechter

Insider Reports History

Entity
Individual
Location
C/O Atrinsic, Inc. 1 Grand Central Place, Suite 2319, New York, NY
Signature
/s/ Jonathan L. Schechter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Schechter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PharmaCyte Biotech, Inc. Director Stock Option (Right to Buy) 38K Apr 30, 2024 Direct
Synaptogenix, Inc. Director Stock Option (Right to Buy) 800 Apr 8, 2024 Direct

Insider Reports Filed by Jonathan Schechter

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PMCB PharmaCyte Biotech, Inc. Apr 30, 2024 1 $0 4 Jul 17, 2024 Director
SNPX Synaptogenix, Inc. Apr 8, 2024 1 $0 4 Apr 10, 2024 Director
PMCB PharmaCyte Biotech, Inc. Nov 20, 2023 1 $0 4 Nov 22, 2023 Director
OBLG Oblong, Inc. May 29, 2023 0 $0 3 Jun 1, 2023 Director
SNPX Synaptogenix, Inc. Mar 29, 2023 1 $0 4 Mar 31, 2023 Director
SNPX Synaptogenix, Inc. Dec 16, 2022 1 -$23.7K 4 Dec 20, 2022 Director
SNPX Synaptogenix, Inc. Nov 15, 2022 1 $0 4 Nov 17, 2022 Director
PMCB PharmaCyte Biotech, Inc. Aug 15, 2022 0 $0 3 Aug 23, 2022 Director
SNPX Synaptogenix, Inc. Apr 5, 2022 1 $0 4/A Jun 23, 2022 Director
SNPX Synaptogenix, Inc. Jul 13, 2021 1 $0 4 Jul 15, 2021 Director
SNPX Synaptogenix, Inc. Jun 4, 2021 0 $0 3/A Jun 17, 2021 Director